Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 6.04
+0.44 (7.86%)
Jul 17, 2026, 5:35 PM CET
Carvolix Market Cap
Carvolix has a market cap or net worth of €331.76 million as of July 17, 2026. Its market cap has increased by 543.62% in one year.
Market Cap
331.76M
Enterprise Value
349.84M
Revenue
900.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.04
ChartMarket Cap Chart
Since June 14, 2021, Carvolix's market cap has increased from 145.31M to 331.76M, an increase of 128.31%. That is a compound annual growth rate of 17.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 331.76M | 387.37% |
| Dec 31, 2025 | 68.07M | 28.15% |
| Dec 31, 2024 | 53.12M | -6.82% |
| Dec 29, 2023 | 57.01M | 86.82% |
| Dec 30, 2022 | 30.52M | -70.47% |
| Dec 31, 2021 | 103.35M | -28.88% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 215.46M |
| Median Technologies | 170.98M |
| Guerbet | 114.80M |
| Theraclion | 49.06M |
| Mauna Kea Technologies | 31.43M |
| Diagnostic Medical Systems | 31.10M |
| Novacyt | 29.67M |
| Implanet | 25.57M |